Introduction {#s1}
============

Multipotent stem cells are essential for both growth and generation of cell diversities in developing organs. They also serve as reservoir to replace damaged or aged cells during physiological or pathological tissue homeostasis. The discovery of a small number of transcription factors that can induce pluripotent cells ([@bib111]) has fueled major research efforts to reveal the mechanisms biasing the choice between pluripotent/multipotent and more differentiated cell fates in vivo ([@bib80]). Using the *Drosophila* airways (tracheal system) ([@bib72]; [@bib96]) ([Figure 1A](#fig1){ref-type="fig"}), we studied how the initial selection of different potencies within an organ becomes first predisposed and then regionally confined.10.7554/eLife.09646.003Figure 1.The proximo-distal cell fate organization of the *Drosophila* airways.(**A**) A sketch of the embryonic *Drosophila* airways at stage 10/11 and late stage 12. (**B**) A representation of the ectodermal expression the secreted signaling molecules *wg/WNT, hh* (upper panel), and *dpp* (lower panel) in relation to the airway primordia at stage 10. (**C--J**) Expression of the P/D-fate markers at different stages of the airway development, which is summarized schematically in **C**, where the regional diversification of the *Drosophila* airway according to the proximo-distal axis is also shown in different colors. The P-fate region: spiracular branch (SB). The D-fate region: transverse connectives (TC) and six primary branches (dorsal branch/DB, dorsal trunk anterior/DTa, dorsal trunk posterior/DTp, visceral branch/VB, lateral trunk anterior/LTa, and ganglionic branch/GB/lateral trunk posterior/LTp). Expression of the D-fate markers, *btl* (D,E), mab2A12 (**F, J**) and the P-fate markers, *P0144-lacZ* (**E, F, I, J**) and *upd* (**G-I**), relative to each other or *trh-lacZ* (**D, G, H**). In this and other figures, arrowheads mark one of the 10 metameres. In **E-F**, enlarged picture of Tr5 is also shown, where the P-fate cells are bracketed. *btl* expression at stage 11 (**D**) is concentrated in the central parts of the primordia. At stage 13 (**E**), *btl* expression and *P0144-lacZ* expression (arrowheads) rarely overlap. At stage 16, mab2A12 (anti-Gasp antibody) strongly labels the lumens of the D-cells while *P0144-lacZ* is strongly detected in the P-cells (**F**, arrowheads). At stage 11 (**G**), *upd* transcript is detected at the peripheral area of each primordium (arrowheads). At stage 13 (**H, I**), *upd* is expressed in the P-cells that express *P0144-lacZ* (arrowheads). Note that compared to the control, where *upd* and *P0144-lacZ* are not expressed in Tr10 (arrows in **F, H**), the P-fate (*P0144-lacZ*) is established in Tr10 of *AbdB* mutants (asterisks in **J**). Scale bar is 2 μm in the enlarged panels of **E-F**. Scale bar in the remaining panels is 50 μm. (**K**) summarizes typical gene expression patterns of various marker genes in the airway primordium and in the mature airways. See text for details.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.003](10.7554/eLife.09646.003)10.7554/eLife.09646.004Figure 1---figure supplement 1.The centro-peripheral organization of the airway primordia.Expression of *rho* (**A-E**), *pnt* (**F-O**), *h* (**P-Q**), or *salm* (**R-T**) in the airways before or after invagination. (**A--E**) *rho* expression in the trachea. At stage 10 (**A**), the dorso-central part of each primordium expresses *rho* (arrowheads). By stage 11 (**B,C**), when the tracheal cells invaginate, *rho* expression expands to cover more cells of the central/distal areas (arrowheads). At late stage 11 (**E,F**), *rho* expression in the dorsal part of the distal trachea becomes weak (**D**, arrowheads), while the ventral part of the distal trachea still retains strong *rho* expression (**E**, arrowheads). (**F--O**) *pnt* expression in the trachea. At early stage 11 (**F**), *pnt* is expressed in the dorso-central part of each primordium (arrowheads), which expands to the whole cental/distal areas (**G-U**). The proximal area expresses less *pnt* (**H**, arrowheads) than the distal area (**I**, arrowheads) as also evident in a section from a ventral view (**J**, arrowheads). At stage 11, compared to the wild type (**K**), *pnt* expression in the primordia is barely detectable in *rho* mutants (**L**, arrowheads). In the wild type (**M**), *pnt-lacZ* is expressed in the distal trachea, with its expression upregulated in a pan-tip pattern due to the Bnl/dFGF-dependent activation of Btl/dFGFR (arrowheads). In *btl* mutants (**N,O**) where this upregulation is absent, *pnt-lacZ* is expressed in the D-cells (arrowheads in Tr7) but is absent in the P-cells (arrows in Tr7). (**P,Q**) *h* expression in the trachea. At stage 10/11 (**P**), *h* is expressed in the dorso-central part of each primordium (arrowheads). At stage 13 (**Q**), expression of *h-lacZ* is detected in DB, DT, and VB (arroheads in Tr5), whereas TC and SB does not express it (arrows in Tr5). Note that the earlier pair-rule pattern of *h-lacZ* expression is also evident (asterisks). (**R--T**) *salm* expression in the trachea. At stage 10/11 (**R**), *salm* is expressed in the dorsal part of each primordium (arrowheads). At stage 13 (**S,T**), *salm-gal4* driven *UAS-nGFP* labels DB, DT (arrowheads in Tr7), and part of TC and SB (arrows in Tr7). (**U,V**) Requirements of *trh* for the P/D fate selection. In *trh* mutants, expression of the P-fate markers *upd* (**U**, stage 13) and *P0144-lacZ* (V, stage 14/15) and the D-fate marker mab2A12 (**V**) is abolished (asterisks). Scale bar: 50 μm. DB, dorsal branch; DT, dorsal trunk; SB, spiracular branch; TC, transverse connectives; VB, visceral branch.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.004](10.7554/eLife.09646.004)

By mid-embryogenesis, *Drosophila* embryos are metamerically divided along the anterior-posterior (AP) axis ([@bib51]; [@bib97]). Each unit (segment or parasegment) is also subdivided along the dorso-ventral (DV) embryo axis ([@bib3]; [@bib119]). Generation of the airway primordia is spatially restricted along these AP or DV axis, by the local concentrations of repressing and activating signals ([@bib6]; [@bib53]; [@bib86]; [@bib121]). For example, Wingless (Wg) expressed in stripes along the AP axis and Decapentaplegic (Dpp) expressed in the dorsal ectoderm ([Figure 1B](#fig1){ref-type="fig"}) repress the airway primordia specification ([@bib53]; [@bib121]). As a result, 10 metameric groups of cells expressing a master gene, Trachealess (Trh) are specified on each side of the lateral ectoderm ([Figure 1A--B](#fig1){ref-type="fig"}). Invagination of each primordial cluster transforms the two-dimensional (2D) shape of each cluster to 3D tubes ([Figure 1C](#fig1){ref-type="fig"}) ([@bib16]; [@bib113]). Within the invaginated primitive sacs/tubes, the proximal cells form a narrow cord, the spiracular branch/SB (P-fate) ([Figure 1C, K](#fig1){ref-type="fig"}) and stay multipotent to later proliferate and to generate many parts of the pupal/adult airways ([@bib72]; [@bib87]; [@bib118]). Within the remaining distal cells (D-fate), the more distal parts achieve a series of morphogenetic events, extending six primary branches, fusing with branches from neighboring metameres and supplying oxygen directly to the target cells ([@bib72]; [@bib95]; [@bib96]), while the more proximal parts (transverse connectives/TC) connect SB with the primary branches ([Figure 1C, K](#fig1){ref-type="fig"}).

The primary branches constitute D-fate cells located distally from TC, and their morphological diversification depends on the activation of various signaling pathways. For example, *rhomboid (rho*) is expressed in each primordium ([@bib7]) and activates *dEGFR* (also called *torpedo* or *faint little ball*) ([@bib88]; [@bib100]) by generating the secreted active ligand Spitz (s-Spi) ([@bib32]; [@bib38]; [@bib103]; [@bib114]; [@bib117]). Activated dEGFR instructs the cytoskeletal changes that coordinate invagination ([@bib10]; [@bib59]; [@bib68]; [@bib79]). Branchless (Bnl)/dFGF is expressed in patches of surrounding tissues to guide primary branching ([@bib110]) by activating Breathless (Btl)/dFGFR on the airway cells ([@bib57]; [@bib64]). Apart from receptor tyrosine kinase (RTK) signaling, Decapentaplegic (Dpp)/BMP, Wingless (Wg)/WNT, and Hedgehog (Hh) signals combinatorially establish different primary branch identities ([@bib1]; [@bib21]; [@bib22]; [@bib37]; [@bib69]; [@bib70]; [@bib73]; [@bib115]). Although many studies focused on the differentiation and subsequent morphogenesis of the D-fate cells ([@bib5]; [@bib14]; [@bib36]; [@bib46]), generation of the P-fate has been underexplored. Our current dissection of P/D fate establishment in the embryo, together with metamere-specific control programs of differentiation/de-differentiation in the larval airways ([@bib28]; [@bib40]; [@bib99]; [@bib118]) may broaden our understanding of the strategies for stem cell selection and maintenance in vivo.

Results and discussion {#s2}
======================

The proximo-distal cell fate organization in the *Drosophila* airway tree {#s2-1}
-------------------------------------------------------------------------

Every cell in the main airways derives from 20 primordial cell clusters expressing the master regulator TF Trh ([Figure 1A--C, K](#fig1){ref-type="fig"}) ([@bib53]; [@bib86]; [@bib121]). However, the expression of several other genes is enriched either distally or proximally in the airways. *rho* is expressed preferentially in the central and distal regions of the airway primordia before and during invagination ([Figure 1---figure supplement 1A--E](#fig1s1){ref-type="fig"}). *btl/dFGFR* is also expressed preferentially in the distal part ([Figure 1D--E](#fig1){ref-type="fig"}), and its expression is upregulated by Bnl/dFGF in the most distal leading cells of the primary branch tips ([Figure 1E](#fig1){ref-type="fig"}) ([@bib84]; [@bib83]). mAb2A12 detecting the putative chitin-biding protein Gasp ([@bib112]) preferentially labels the distal airways during stages 14-17 ([Figure 1F](#fig1){ref-type="fig"}) ([@bib95]). On the other hand, *unpaired (upd*), a ligand activating the JAK/STAT signaling is expressed only in the proximal SB cells from stage 12 on ([Figure 1G--I](#fig1){ref-type="fig"}) ([@bib41]). From stage 13 onwards, the SB cells also show stronger expression of the *P0144* enhancer trap marker ([Figure 1E,F,I](#fig1){ref-type="fig"}) (<http://flyview.uni-muenster.de>). Compared to the anterior metameres, the 10^th^ tracheal primordium (Tr10) does not establish the *P0144-*postive P-fate due to the high level of a Hox protein Abdominal-B (AbdB) in this part of the embryo ([Figure 1F, J](#fig1){ref-type="fig"}), ([@bib19]; [@bib73]). In *trh* mutants, both the D-fate marker ([@bib24]; [@bib54]; [@bib83]; [@bib122]) and the P-fate marker expressions ([Figure 1---figure supplement 1U, V](#fig1s1){ref-type="fig"}) are lost.

To define the origins of the proximo-distal organization of the airway tree, we labeled cell groups during the 2D primordial stage and recorded their fates in the 3D tree. *pointed (pnt*) is a general transcriptional target and mediator of RTK signaling ([@bib13]; [@bib58]; [@bib81]). *rho* induces *pnt* expression in the central parts of the airway primordia ([Figure 1---figure supplement 1F--O](#fig1s1){ref-type="fig"}) and *btl/dFGFR* upregulates *pnt* expression in the tips of the primary branches ([Figure 1---figure supplement 1M--O](#fig1s1){ref-type="fig"}) ([@bib95]). Markers of the central parts of the airway primordia (*pnt-lacZ* and *btl-CD8-GFP*) become preferentially expressed in the distal part of the airway tree ([Figure 1K](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1N--O](#fig1s1){ref-type="fig"}). Similarly, *hairy (h*) expression in the airway primordia ([@bib18]; [@bib44]; [@bib123]) is confined to the dorso-central part ([Figure 1---figure supplement 1P](#fig1s1){ref-type="fig"}) and its reporter (*h-lacZ*) becomes active in most of the DB, VB, and DT cells but not in TC, SB nor in ventral branches ([Figure 1K](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1Q](#fig1s1){ref-type="fig"}) ([@bib95]). In contrast, *salm* labels the dorsal part of the airway primordia ([Figure 1---figure supplement 1R](#fig1s1){ref-type="fig"}), ([@bib61]) and *salm-gal4* driven *UAS-GFP* marks DB and DT, and parts of TC and SB in the airways ([Figure 1K](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1S--T](#fig1s1){ref-type="fig"}). These results suggest that the dorso-peripheral sector of each primordium, which is positive for *salm* but lacking *h*, composes half of the proximal SB cells in the airway tree. The other half may originate from the ventro-peripheral sector of the primordia. Consistently, around the completion of invagination, the P-fate marker *upd* is enriched in a horseshoe-like peripheral ring ([Figure 1G](#fig1){ref-type="fig"})([@bib41]), which eventually marks the SB cells at stage 12 ([Figure 1H,I,K](#fig1){ref-type="fig"}). Collectively, the gene expression analysis suggests a fate map of the airway primordia, where the centro-peripheral axis inversely correlates both with the ordered pattern of tracheal cell invagination ([@bib10]; [@bib79]) and the PD axis of airway branching ([Figure 1C,K](#fig1){ref-type="fig"}).

RTK signaling drives the D-fate selection at the expense of the P-fate {#s2-2}
----------------------------------------------------------------------

As activation of RTKs propels several morphogenetic programs in the D-cells, we first assessed their effects on the discrimination of the P- and the D-fate. In *btl/dFGFR* mutants, where active branch extension does not occur, apoptotic staining in the distal cells increases from stage 12 ([Figure 2---figure supplement 1A,B](#fig2s1){ref-type="fig"}), suggesting that *btl/dFGFR* signaling directly or indirectly suppresses apoptosis of the distal airways. In *dEGFR btl/dFGFR* double mutants, massive cell death staining accompanies loss of most tracheal cells compared to either single mutant ([Figure 2---figure supplement 1B--D](#fig2s1){ref-type="fig"}). Suppression of apoptosis by removing pro-apoptotic genes using *Df(H99)* ([Figure 2---figure supplement 1E](#fig2s1){ref-type="fig"}) ([@bib120]) or by transgenic expression of the apoptosis inhibitor, DIAP ([Figure 2---figure supplement 1F](#fig2s1){ref-type="fig"}) ([@bib42]) partially restores the survival of tracheal cells in *dEGFR btl/dFGFR* double mutants ([Figure 2---figure supplement 1E--J](#fig2s1){ref-type="fig"}). Thus, dEGFR and Btl/dFGFR cooperate to suppress apoptosis in the airway cells. To analyze the effects of RTK signaling in the P/D fate choice independently of cell survival, we introduced *Df(H99)* into some of the genotypes used in the analysis described below.

In *bnl/dFGF* mutants, the feedback upregulation of the D-fate marker *btl/dFGFR* is lost in the tips of the primary branches ([Figure 2A,B](#fig2){ref-type="fig"}) ([@bib84]). However, the distal part of the invaginated stump retains the mab2A12 signal ([@bib64]) and the basal *btl/dFGFR* expression ([Figure 2B](#fig2){ref-type="fig"}). Similarly, expression of the P-fate markers (*upd* and *P0144-lacZ*) in *btl/dFGFR* mutants remains largely comparable to the wild type ([Figure 2E--F, I--J, M](#fig2){ref-type="fig"}). These results suggest that Btl/dFGFR signaling does not play a major role in the P-D discrimination. In *rho* mutants, however, the refinement of *upd* expression to the primordia periphery is retarded ([Figure 2---figure supplement 1K,L](#fig2s1){ref-type="fig"}), and the expression domains of *upd* and *P0144-lacZ* become expanded ([Figure 2G, K, M](#fig2){ref-type="fig"}). Correspondingly, the domain of *btl*-expressing cells is decreased ([Figure 2C](#fig2){ref-type="fig"}) suggesting that the *rho-*mediated *dEGFR* signaling drives the D-fate selection at the expense of the P-fate. We investigated the possible redundant functions of the two RTKs in D-fate definition. In *rho bnl/dFGF* double mutants, *btl* expression is further reduced or even lost in some segments ([Figure 2D](#fig2){ref-type="fig"}). Correspondingly, in *rho btl/dFGFR* double mutants, another D-fate marker mab2A12/Gasp becomes reduced or undetectable in some segments, accompanied by a concomitant increase of the proximal *P0144-lacZ* expression domain ([Figure 2L, N](#fig2){ref-type="fig"}). Consistent with the phenotypes of *rho btl/dFGFR* mutants, *P0144-lacZ* expression is also increased in *pnt* mutants, ([Figure 2M](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1P](#fig2s1){ref-type="fig"}). Taken together, we conclude that *dEGFR* signaling in cooperation with *btl/dFGFR* signaling promotes the D-fate selection at the expense of the P-fate partly through *pnt* ([Figure 2O](#fig2){ref-type="fig"}). The residual weak expression of the D-fate markers in *rho btl* or *dEGFR btl/dFGFR* double mutants ([Figure 2L](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1M--O](#fig2s1){ref-type="fig"}) suggests additional inputs in the D fate selection, independent of RTK signaling downstream of *dEGFR* and *btl/dFGFR* ([Figure 2O](#fig2){ref-type="fig"}).10.7554/eLife.09646.005Figure 2.RTK activation drives the D-fate selection.Expression of the D-fate (*btl* in A-D and mab2A12 in I-L) and the P-fate (*upd* in E-H and *P0144-lacZ* in I-L) markers upon loss of *dEGFR* and/or *btl/dFGFR* signaling. (**A--H**) Stage 12/13. (**I--L**) Stage 16. Compared to the control (**A, E, I**), in *bnl* mutants (**B**), *btl* mutants (**F**) or *Df(H99) btl* mutants (**J**), expression of the D-fate markers *btl* (**A**) and mab2A12 (**J**) and the P-fate markers *upd* (**F**) and *P0144-lacZ* (**J**) appears similar. Note, however, that upregulation of *btl* in a pan-tip pattern is abolished in *bnl* mutants (**B**) ([@bib84]). In *rho* mutants (**C, G**) or *Df(H99) rho* mutants (**K**), the expression area of the P-fate markers *upd* (**G**) and *P0144-lacZ* (**K**, arrowheads) is increased, leading to the decreased area of the D-fate marker expression (**C, K**). In *rho bnl* double mutants (**D**), *rho btl* double mutants (**H**) or *Df(H99) rho btl* triple mutants (**L**), the P-fate area is further expanded with concomitant reduction of the D-fate markers. Note that in **D,L** expression of the D-fate markers becomes reduced very much in a few segments (asterisk). Scale bar is 2 μm in the enlarged panels of **I-L** where the P-fate cells are bracketed. Scale bar in the remaining panels is 50 μm. (**M,N**) Scatter plots of the number of *P0144-lacZ* positive P-fate cells in Tr5 and Tr6 of the indicated genotypes at stage 16. All p-values were calculated by Student's t-test. Source files are supplied in [Figure 2---source data 1](#SD1-data){ref-type="supplementary-material"},[2](#SD2-data){ref-type="supplementary-material"}. (**O**) A scheme of P/D-fate selection by RTK signaling components. RTK, receptor tyrosine kinase.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.005](10.7554/eLife.09646.005)10.7554/eLife.09646.006Figure 2---source data 1.Source data for [Figure 2M](#fig2){ref-type="fig"}.The number of *P0144-lacZ*-positive P-fate cells in Tr5 and Tr6 of the indicated genotypes at stage 16.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.006](10.7554/eLife.09646.006)10.7554/eLife.09646.007Figure 2---source data 2.Source data for [Figure 2N](#fig2){ref-type="fig"}.The number of *P0144-lacZ*-positive P-fate cells in Tr5 and Tr6 of the indicated genotypes at stage 16.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.007](10.7554/eLife.09646.007)10.7554/eLife.09646.008Figure 2---figure supplement 1.Multiple roles of *dEGFR* and *btl/dFGFR* signaling.(**A--D**) RTKs promote cell survival of the tracheal cells. Single metameres in stage 13 embryos are marked with arrowheads. Compared to the control, many tracheal cells become positive for TUNEL signals in *btl* mutants (**B**). Upon loss of both RTKs, *dEGFR* and *btl/dFGFR* (C), more cells become positive for TUNEL signals, compared to either single mutants (**B, D**). (**E--J**) Branching phenotypes and rescue of *dEGFR btl/dFGFR* double mutants. Single metameres in stage 15 embryos are marked with arrowheads. In *dEGFR btl/dFGFR* double mutants (**E**), there is no branching and almost no mab2A12 signals. By suppressing apoptosis with *Df(H99)* (**F**) or DIAP overexpression (**G**), as well as by expression of *Ras^V12^* (**H**), *dEGFR* (**I**), or *btl/dFGFR* (**J**) mab2A12 signals are significantly restored. (**K--P**) Roles of RTK signaling components in the P/D fate selection. Compared to the control (**K**), in *rho* mutants (**L**), repression of the P fate marker *upd* in the D cells is retarded at stage 11/12 (arrowheads). In *Df(H99) dEGFR* double mutants (**M**), there are metameres with significantly less P0144-lacZ-positive cells than in *Df(H99) rho* double mutants (arrowheads). *Df(H99) dEGFR btl/dFGFR* triple mutants (**N**) additionally lose mab2A signals in some metameres (arrowheads). *Ras85D* maternal and zygotic mutants harboring *Df(H99)* (**O**) have similar phenotypes as *Df(H99) dEGFR btl/dFGFR* triple mutants (arrowheads). In *Df(H99) pnt* double mutants (**P**), *P0144-lacZ*-positive cells are increased in number as in *Df(H99) rho* double mutants (arrowheads). Scale bar: 50 μm. RTKs, receptor tyrosine kinases.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.008](10.7554/eLife.09646.008)

vvl drives the D-fate selection at the expense of the P-fate {#s2-3}
------------------------------------------------------------

The expression of two key components of RTK signaling, *rho* in the central part of the airway primordia and *btl* in the extending distal airways, partly depends on the POU-domain transcription factor *vvl* ([@bib4]; [@bib67]). We confirmed that in *vvl* mutants, expression of the D-fate markers *rho* and *btl* is reduced ([Figure 3A, B, E, F](#fig3){ref-type="fig"}). Moreover, mAb2A12 staining is almost diminished ([Figure 3N, O](#fig3){ref-type="fig"}) in the residual distal branches, which is restored by *UAS-vvl* driven with *btl-gal4* ([Figure 3---figure supplement 1T](#fig3s1){ref-type="fig"}). By contrast, the expression of the P-fate marker *upd* is expanded to the distal branches at stage 12 ([Figure 3J--K](#fig3){ref-type="fig"}) and the *P0144-lacZ* domain is significantly increased at stage 15 in *vvl* mutants ([Figure 2N](#fig2){ref-type="fig"}, [3O](#fig3){ref-type="fig"}). This indicates that *vvl* promotes the D-fate at the expense of the P-fate, and a part of this function may be achieved through *vvl*-dependent expression of *rho* and *btl*. In wild type, *vvl* expression is enriched in the distal trachea, indicating that *vvl* itself is a D-fate marker ([Figure 3---figure supplement 1A--C](#fig3s1){ref-type="fig"}).10.7554/eLife.09646.009Figure 3.Hh and Vvl drive the D-fate selection.Expression of the D-fate markers (*rho* at stage 11 in **A--D**, *btl* at stages 11-13 in **E--I** and mab2A12 at stages 15/16 in **N--Q**) and the P-fate markers (*upd* at stages 12/13 in **J--M**, *P0144-lacZ* in **N-Q**) upon loss of *vvl* and/or *hh*. Note that the genotypes in (**N-Q**) additionally carry the *Df(H99)* mutation. Compared to the control (column 1), upon loss of *vvl* (column 2), the expression area of the D-fate markers *rho* (**B**), *btl* (**F**), and mab2A12 (**Q**) is decreased while expression of the P-fate markers *upd* (**K**) and *P0144-lacZ* (**Q**) is expanded. Note that mab2A12 signals are hardly detectable in **O**. *hh* mutants (column 3) show the same trend as *vvl* mutants. Expression of *btl* (**G**) and mab2A12 (**P**) is variably lost in Tr3/4 and *upd* expression (**P**) expands to the whole distal area. In *hh vvl double* mutants (column 4), expression of the D-fate markers (**D,I**) is lost, while expression of the P-fate markers (**M,Q**) persist in the whole trachea. Note that weak *btl* expression is detectable in the primordia (**H**) but is lost soon after (**I**). Scale bar: 50 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.009](10.7554/eLife.09646.009)10.7554/eLife.09646.010Figure 3---figure supplement 1.Hh, Vvl, and RTKs collaborate to drive the D-fate selection.(**A--D**) *vvl* expression. *vvl* is expressed in the epidermis and in the central/distal part of each primordium/metamere (**A**). At stage 13 (**B**), tracheal *vvl* expression is predominant in the D-cells that are negative for *P0144-lacZ*. Compared to the wild type (**C**), *vvl* expression is variably decreased in *hh* mutants (**D**). (**E--I**) Comparison of double or triple mutants of *vvl* and RTKs. Loss of *vvl* and *dEGFR* signaling: *vvl rho* double mutants (E) or *Df(H99) vvl rho* triple mutants (**J**). Loss of *vvl* and *btl/dFGFR* signaling: *vvl bnl* double mutants (F) or *Df(H99) vvl btl* triple mutants (**K**). Loss of *vvl* and RTK signaling: *vvl rho bnl* triple mutants (**G,H**) and *Df(H99) vvl rho btl* quadruple mutants (**L**). Compared to loss of *vvl* and single RTK signaling components, upon loss of *vvl* and 2 RTK signaling factors, more cells lose expression of the D fate marker *btl* (**E-H**). Note that in *vvl rho bnl* triple mutants (**G,H**), *btl* expression initiates in the primordia (**G**) but is not maintained (**H**). Instead, the tracheal cells express the P-fate marker *upd* (**I**). A similar trend is seen for another pair of the P/D cell fate markers, mab2A12 and *P0144-lacZ* (**J-L**). (**M--S**) Comparison of double and triple loss of *hh* and *dEGFR* signaling. Loss of *hh* and *dEGFR* signaling: *hh rho* double mutants (**M**) or *Df(H99) hh rho* triple mutants (**Q**). Loss of *hh* and *btl/dFGFR* signaling: *hh bnl* double mutants (**N**) or *Df(H99) hh btl* triple mutants (**R**). Loss of *hh* and 2 RTK signaling components: *hh rho bnl* triple mutants (**O**) and *Df(H99) vvl btl rho* quadruple mutants (**S**). Compared to loss of *hh* and a single RTK signaling factor, upon loss of *hh* and 2 RTK signaling components, more cells lose expression of the D fate markers *btl* (**O**) and mab2A12 (**R**). Concomitantly, many of the tracheal cells become positive for the P-fate marker *upd* (**P**) and *P0144-lacZ* (**S**). (**T**) Loss of mab2A12 signal in *vvl* mutants is partially restored by *btl-gal4* mediated overexpression of *vvl*. Scale bar: 50 μm. RTK, receptor tyrosine kinase.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.010](10.7554/eLife.09646.010)

The residual expression of the RTK signaling components in *vvl* mutant may function as D-factors in the absence of *vvl*. To evaluate the relative contributions of *vvl* and RTKs in the P/D fate selection, we examined double or triple mutants of *vvl* and components of the two RTK signaling pathways. Compared to single or double mutants ([Figure 3---figure supplement 1E, F](#fig3s1){ref-type="fig"}), in *vvl rho bnl* triple mutant embryos, the expression of the D-fate marker *btl* is initiated at stage11 but is not maintained by stage 12 ([Figure 3---figure supplement 1G,H](#fig3s1){ref-type="fig"}). Consistently, the mab2A12 signal is undetectable in *vvl rho btl* mutants ([Figure 3J--L](#fig3){ref-type="fig"}). In contrast, expression of the P-fate markers *upd* and *P0144-lacZ* appears to be expressed in all tracheal cells ([Figure 2N](#fig2){ref-type="fig"}, [Figure 3---figure supplement 1I, L](#fig3s1){ref-type="fig"}). These results suggest that the two RTK pathways act both downstream of and in parallel to *vvl* to drive the D-fate selection at the expense of the P-fate.

Hh and Vvl drive the D-fate selection {#s2-4}
-------------------------------------

Hh is expressed just anteriorly to the airway primordia ([@bib37]) and is proposed to enhance the primordial *vvl* expression ([@bib67]). We confirmed that in *hh* mutants, *vvl* expression is variably decreased or lost ([Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}). Consistently, expression of the D-fate markers *rho* and *btl* is also variably decreased or lost in *hh* mutants ([Figure 3C,G](#fig3){ref-type="fig"}, in 6 out of 26 embryos for *btl* expression). In contrast, expression of the P-fate marker *upd* is expanded and sometimes occupies the whole trachea in some segments of *hh* mutants ([Figure 3L](#fig3){ref-type="fig"}). A similar effect is observed on the expression of a different set of the P/D fate markers, mab2A12/Gasp and *P0144-lacZ* ([Figure 3P](#fig3){ref-type="fig"}). These results suggest that Hh signals from the anterior border of the airway primordia to orient the P/D fate selection toward the D-fate direction. Similar to the cooperative activities of *rho, btl,* and *vvl, hh* could synergize with *vvl* to drive the D-fate. Indeed, in the absence of both *hh* and *vvl*, although expression of the D-fate markers *rho* and *btl* is variably detected in the primordia ([Figure 3D,H](#fig3){ref-type="fig"}), *btl* expression is completely absent later ([Figure 3I](#fig3){ref-type="fig"}). Correspondingly, the expression of P-fate markers expands to all tracheal cells ([Figure 3M,Q](#fig3){ref-type="fig"}). A similar trend was observed in mutants for *hh* and RTK signaling components ([Figure 3---figure supplement 1M--S](#fig3s1){ref-type="fig"}). Taken together, we conclude that Hh and Vvl cooperatively drive the D fate selection, partly through the activation of *dEGFR* and *btl/dFGFR* signaling in the central part of the primordium and in the distal branches.

Grn promotes the P-fate selection {#s2-5}
---------------------------------

The identification of several signaling pathways converging in the initiation and establishment of the D-fate in the airways prompted us to interrogate what promotes the P-fate. We revealed the GATA-family TF Grn ([@bib11]; [@bib34]; [@bib65]) as the P-fate promoting factor. *grn* is preferentially expressed in the peripheral parts of the airway primordia from stage 11 on ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). At stage 13, the P-fate cells of the SB and the overlying lateral ectoderm are positive for *grn* ([Figure 4---figure supplement 1B--C](#fig4s1){ref-type="fig"}). *grn* expression is repressed in the D-cells by the D-fate determinants, *hh, vvl,* and RTKs ([Figure 4---figure supplement 1D--G](#fig4s1){ref-type="fig"}), while *grn* expression in the lateral ectoderm is largely intact in the absence of tracheal cells in *upd* or *trh* mutants ([Figure 4---figure supplement 1H--I](#fig4s1){ref-type="fig"}). Grn overexpression results in the upregulation of the P-fate marker *P0144-lacZ* in the more distal TC branches ([Figure 4A--C](#fig4){ref-type="fig"}). Conversely, in *grn* mutants, expression of the P-fate markers *upd* and *P0144-lacZ* is lost ([Figure 4D--F](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1J](#fig4s1){ref-type="fig"}), resulting in mAb2A12-positive tubes directly connecting to the epidermis. Counting the Trh-positive cells in Tr5 and in TC5/SB5 reveals that around 10 cells are selectively lost from the TC/VB region ([Figure 4G](#fig4){ref-type="fig"}). As halving of the airway cell number in CycA mutants ([@bib5]) does not abolish the P-fate ([Figure 4H](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1K](#fig4s1){ref-type="fig"}), we suggest that reduction of cell number does not account for the loss of the P-fate in *grn* mutants. Also, *arm-gal4*-mediated overexpression of Trh in *grn* mutants does not restore the P-fate ([Figure 4H](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1L](#fig4s1){ref-type="fig"}). These results suggest that *grn* functions in two ways, namely to establish Trh expression in the P-region and to induce the P-fate marker expression ([Figure 4K](#fig4){ref-type="fig"}). Accordingly, we designate *grn* a master regulator of the P-fate.10.7554/eLife.09646.011Figure 4.Grn promotes the P fate.Compared to the control (**A**), *grn* overexpression with *arm-gal4* (**B**) or two copies of *btl-gal4* and *trh-gal4* (**C**) slightly expands the area of *P0144-lacZ* positive cells to more distal TC areas, especially in Tr2-5 (**B-C**, arrows). In *grn* mutants, expression of the P-fate markers *upd* (**D**) or *P0144-lacZ* (**E**) disappears while *arm-gal4-*mediated Grn overexpression restores *P0144-lacZ* expression in the proximal cells (**F**). (**G**) Scatter plots of the Trh-positive cell numbers in the whole Tr5 or in the SB/TC subregion of the indicated genotypes at stage 14 (mean ± SEM, N = 5; all p-values were calculated by Student's t-test). The cell number is decreased by around 10 cells in *grn* mutants in Tr5 and in the SB/TC subregion. A source file is supplied in [Figure 4---source data 1](#SD3-data){ref-type="supplementary-material"}. (**H**) Scatter plots of the number of metameres with any number of *P0144-lacZ-*positive cells of the indicated genotypes at stages15/16 (NS: not significant by Student's t-test). Note that grn mutants occasionally possess a few *P0144-lacZ* cells in anterior metameres. A source file is supplied in [Figure 4---source data 2](#SD4-data){ref-type="supplementary-material"}. (**I**) summarizes the two functions of *grn* in P-fate promotion. Scale bar: 50 μm. SB, spiracular branch; SEM, standard error of the mean, TC, transverse connectives.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.011](10.7554/eLife.09646.011)10.7554/eLife.09646.012Figure 4---source data 1.Source data for [Figure 4G](#fig4){ref-type="fig"}.The Trh-positive cell numbers in the whole Tr5 or in the SB/TC subregion of the indicated genotypes at stage 14.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.012](10.7554/eLife.09646.012)10.7554/eLife.09646.013Figure 4---source data 2.Source data for [Figure 4H](#fig4){ref-type="fig"}.The number of metameres with any number of *P0144-lacZ-*positive cells of the indicated genotypes at stages 15/16.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.013](10.7554/eLife.09646.013)10.7554/eLife.09646.014Figure 4---figure supplement 1.Regulation and function of *grn* expression.(**A--C**) *grn* expression in wild type. At stage 11 (**A**), *grn* is preferentially expressed in the periphery of the tracheal primordia (arrowheads). At stage 13 (**B,C**), *grn* is detected in the P-cells (**B**) positive for *P0144-lacZ* (C) (arrowheads) as well as in the lateral ectoderm. (**D--I**) *grn* expression in mutants. *grn* expression expands to the D-cells in *hh vvl* double mutants (**D**, stage 12) or *vvl rho btl* triple mutants (**E**, stage 12/13). Loss of two RTK signaling components (**F**, stage 12, arrowheads in Tr7) or the downstream mediator *Ras85D* (**G**, stage 12) has weaker effects compared to *hh vvl* double mutants and the distal area variably becomes positive for *grn* (arrowheads). Note that the *Df(H99)* mutation is introduced in (**F,G**) to suppress apoptosis. In *Df(upd)* (**H**, stage 13) or *trh* mutants (**I**, stage 13), *grn* expression in the lateral ectoderm is largely intact, with some defects in *Df(upd)* mutants. Expression of the P-fate marker *upd* is abolished in *grn* mutants (**J**, stage 13). In *CycA* mutants (**K**, stage 15), the number of *P0144-lacZ*-positive cells becomes reduced but not abolished, while *arm-gal4-*mediated overexpression of *trh* does not restore *P0144-lacZ* expression in *grn* mutants (**L**, stage 15). Scale bar: 50 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.014](10.7554/eLife.09646.014)

Effects of simultaneous loss of the D- and P-factors {#s2-6}
----------------------------------------------------

Having identified several regulators of the D- and P-fates, we examined their epistatic relationships. Compared to the control ([Figure 5A](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1E, J](#fig5s1){ref-type="fig"}), in *grn hh* double- ([Figure 5C](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1G, L](#fig5s1){ref-type="fig"}) or *grn rho btl* triple mutants ([Figure 5---figure supplement 1I, N](#fig5s1){ref-type="fig"}), the P-fate marker expression is not robustly restored. In *grn vvl* double mutants, the *trh* expression area appears to be very much reduced ([Figure 5F](#fig5){ref-type="fig"}), probably because the P-fate cells depend on *grn* for *trh* expression. However, in this reduced area of the distal region, we detected weak restoration of the P-fate markers *upd* and *P0144-lacZ* ([Figure 5B](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1F, K](#fig5s1){ref-type="fig"}). These results may suggest the presence of another factor in the distal area that promotes the P-fate when *grn* and *vvl* are inactivated. Alternatively, the default airway cell fate is the proximal and multipotent cell fate (the P-fate) and an important aspect of the *grn* functions in P-fate selection/promotion maybe to antagonize the D-factor *vvl*. In the absence of both the D- and P-factors ([Figure 5H](#fig5){ref-type="fig"}, [Figure 5---figure supplement 2A--B](#fig5s2){ref-type="fig"}), *trh* expression initiates at stage 10 but becomes drastically reduced by stage 12/13 ([Figure 5E--H](#fig5){ref-type="fig"}). In these mutants ([Figure 5D](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1D, H, M](#fig5s1){ref-type="fig"}, [Figure 5---figure supplement 2A--B](#fig5s2){ref-type="fig"}), the expression of both proximal and distal markers is almost completely eliminated ([Figure 5A--D](#fig5){ref-type="fig"}. [Figure 5---figure supplement 1A--N](#fig5s1){ref-type="fig"}). We conclude that the regulators of the D- and P-fate cooperatively promote and maintain the airway cell identity defined by *trh* expression. Below, we first describe roles of the embryo axis determinants on P/D-fate selection and then proceed to dissect the function of D-factors by gain-of-function approaches.10.7554/eLife.09646.015Figure 5.Genetic interactions of *grn, hh,* and *vvl*Expression of the P-fate marker *upd* (**A--D**, stages 12-13) or the pan-tracheal marker *trh* (**E--H**, stages 12-13) are shown. Loss of *upd* expression in *grn* mutants (**A**) is partially reversed by *vvl* mutation (**B**, arrowheads) but not by *hh* mutation (**C**). In the absence of all, *grn, hh,* and *vvl, upd* expression is virtually lost (**D**). This accompanies severe reduction of *trh* expression (**H**, arrowheads), compared to either *grn* (**E**), *grn vvl* (**F**), or *grn hh* double mutants (**G**). Note the *trh-lacZ* expression in **H**, reflecting initial *trh* expression at the primordia stage. Also, expression of *trh* and *upd* in Tr1 is often detected at stage 12. Asterisks in **G** marks loss of *trh* expression in Tr3. Scale bar: 50 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.015](10.7554/eLife.09646.015)10.7554/eLife.09646.016Figure 5---figure supplement 1.Genetic analysis of *grn, hh, vvl,* and RTK components.Expression of the D-fate marker (*btl* in **A--D** or mab2A12 in **E--I**) or the P-fate marker (*P0144-lacZ* in **E--N**) is shown. Compared to *grn* (**A**), *grn vvl* (**B**), or *grn hh* (**C**) mutants, in *grn hh vvl* triple mutants, *btl* expression is largely lost as in *hh vvl* double mutants. Loss of *P0144-lacZ* expression in *grn* mutants (**E,J**) is partially restored in *grn vvl* double mutants (F,K) but not significantly in *grn hh* double mutants (**G,L**) or in *grn rho btl* triple mutants (**I,N**). Restoration of the P-fate in *grn vvl* double mutants is suppressed in *grn vvl hh* triple mutants (**H, M**). Note the presence of *Df(H99)* mutation in **J--N**. Arrowheads in **E-N** mark the proximal location of the tracheal cells. Scale bar: 50 μm. RTK, receptor tyrosine kinase.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.016](10.7554/eLife.09646.016)10.7554/eLife.09646.017Figure 5---figure supplement 2.Phenotypes caused by simultaneous loss of the D- and P-factors.Expression of pan-tracheal marker (*trh*) and the P-fate marker (*P0144-lacZ*). Either in *Df(H99) grn hh vvl* quadruple (**A**) or *Df(H99) grn vvl rho btl* quintuple mutants (**B**), the P-fate is not established and Trh expression becomes significantly reduced by stage 13/14. Arrows point persistent Trh expression in part of the posterior spiracle, which originates from a primordium specified in connection to Tr10 ([@bib48]). Scale bar: 50 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.017](10.7554/eLife.09646.017)

Wg/WNT and Dpp/BMP signaling converge on the P/D-fate selection {#s2-7}
---------------------------------------------------------------

A key aspect of the P/D-fate selection in the *Drosophila* airways is the separation of the *trh* positive airway primordia into a D-fate circle (*vvl, rho* and *btl* positive) surrounded by a concentric P-fate ring (*grn* and *upd* positive). To investigate the origins of this rough setup, we examined the effects of Wg/WNT and Dpp/BMP ([Figure 1B](#fig1){ref-type="fig"}), two major axis determinants along the AP or DV axis, respectively ([@bib27]; [@bib119]).

In *wg/WNT* mutants, expression of the D-fate markers *vvl* ([@bib26]), mab2A12 ([@bib69]), and *btl* expands along the AP axis to cover most, if not all lateral parts of the embryos as a single band ([Figure 6A--B, I](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}). On the other hand, expression of the P-fate markers *grn, upd,* and *P0144-lacZ* also expands along the AP axis, but this time, approximately forms two narrow stripes, dorsal and ventral, sandwiching the D-fate ([Figure 6C, I](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1A--B](#fig6s1){ref-type="fig"}). These results suggest that Wg/WNT confines both the D- and P-fates along the AP axis ([Figure 6I](#fig6){ref-type="fig"}).10.7554/eLife.09646.018Figure 6.Regulation of the P/D fate selection by Wg/WNT and Dpp/BMP.Expression regions of the D-fate markers (*vvl* in **A, D**, *btl* in **B, E** or Gasp in **H**) or the P-fate markers (*upd* in **C, F** or *P0144-lacZ* in **H**) are shown for *wg* mutants (**A--C**), *dpp* hypomorph (*dpp^hr92^*) (**D--F**) or *dpp^hr92^ wg* double mutants (**H**). (**D-F**) are dorsal views where both left (**L**) and right (**R**) sides are seen. In *wg* mutants, expression domains of the D-fate markers expand along the AP axis (**A,B**), and form a single lateral band (bracket) with occasional interruptions before the initiation of primordia invagination (**A**, stage 10). After invagination (**B,C**, stage 12), some D-fate cells remain exposed at the embryo surface to form a lateral band (**B**). The P-fate markers form a dorsal and a lateral band of expression at the ectoderm (**C**, arrowheads). In *dpp^hr92^* mutants (**D-F**), the airway primordia expand to the dorsal midline (**D**, stage 10). Concomitantly, both the D-fate (**D,E**) and the P-fate (**F**) expand to the dorsal midline. Note that the P-fate encircles the D-fate (arrowheads) and that the anterior cells often do not express the P-fate marker *upd* in (**F**, stage 11/12), probably due to the distalization by Hh that is expressed in the anterior border of each primordium. In *dpp^hr92^ Df(wg)* double mutants (**G,H**), the whole dorsal area of the trunk/abdominal body parts become Trh positive at stage 11 (**G**). At stage 14/15 (**H**), the P-fate (arrowheads) is specified abutting the D-fate only at the ventral edge. Note that in the posterior part, the P-fate is not established as it is not established in the wild type. Scale bar: 50 μm. (**I**) Interpretation of data in each genotype regarding specification of the airway field (left parts) and P/D-fate selection (right parts). Expression domains of *dpp* and wg are colored pink and orange, respectively. In *wg* mutants, the airway field (light blue) expands along the AP axis (arrows) and the P-fate is established approximately as a dorsal and a ventral stripes (light green). In *dpp* hypomorphs (*dpp^hr92^*), the airway field expands dorsally to the dorsal midline and the P-fate is established in the periphery except for the anterior and dorsal margin. In double mutants of *wg* and *dpp* hypomorph, the airway field expands both dorsally and along the AP axis, and the P-fate is only established in a ventral stripe.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.018](10.7554/eLife.09646.018)10.7554/eLife.09646.019Figure 6---figure supplement 1.Role of *wg* in P/D fate selection.Expression of the P-fate marker *grn* (**A**) or *P0144-lacZ* (**B**) or the D-fate marker mab2A12 (**B**) in *wg/WNT* mutants. Note that at stage 14/15 (**B**), the P-fate cells (arrowheads) that reside at the embryo surface surround the D-fate cell fraction that still remain at the surface (bracket). Scale bar: 50 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.019](10.7554/eLife.09646.019)10.7554/eLife.09646.020Figure 6---figure supplement 2.Roles of *dpp* in P/D fate selection.(**A--X**) Expression of the D fate markers (*vvl* in **A,F**, *btl* in **B,C,G**) or the P-fate markers (*upd* in **D,H** or *grn* in **E,I,J**) in *dpp* null mutants (*dpp^H46^*) (**A-E**), *dpp^H46^/dpp^hr92^* heterozygotes (**F-I**) or *dpp^hr92^* homozygotes. In *dpp^H46^* mutants, expression of both the D-fate (**A-C**, arrowheads) and the P-fate (**D,E**) is not established. Note that the weak early expression of *btl* (**B**, arrowheads) is not maintained (**C**). In *dpp^H46^/dpp^hr92^* mutants, both the D fate (**F,G**) and the P fate (**H,I**) are established only around the dorsal midline (arrowheads). In *dpp^hr92^* mutants, *grn* expression surrounding the airway cells expands to the dorsal midline (**J**, arrowheads). Scale bar: 50 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.020](10.7554/eLife.09646.020)10.7554/eLife.09646.021Figure 6---figure supplement 3.Roles of *D-factors* in *h* expression.Expression of *h-lacZ* (**A--D**, stage 13) or *h* transcript (**E--H**, stage 10/11) is shown. *h-lacZ* marks the dorso-distal area of the trachea in *btl* mutants (**A**, arrowheads in Tr5) as in the wild type. This distal expression is significantly reduced (arrowheads) in *hh* (**B**), *rho* (**C**) or *pnt* mutants (**D**). Compared to the control (**E**), in *wg* mutants (**F**) *h* expression slightly expands along the AP axis with many gaps remaining. Upon overactivation of *hh* in *wg* mutants by *hh* overexpression (**G**) or *ptc* mutation (**H**), *h* expression expands along the AP axis to form a continuous band. Scale bar: 50 μm. AP, anterior-posterior.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.021](10.7554/eLife.09646.021)

The dorsal and ventral stripes of the proximal markers surrounding the expanded airways in *wg/WNT* mutants suggest that there are cues driving the P/D fate selection along the DV axis. Dpp/BMP presents a top candidate for such a signal ([@bib53]; [@bib121]). In the absence of *dpp, trh* expression expands to the dorsal midline ([Figure 6---figure supplement 2A, D](#fig6s2){ref-type="fig"}) ([@bib53]) and the cells initiate *btl* expression ([Figure 6---figure supplement 2B](#fig6s2){ref-type="fig"}). However, neither the D-fate nor the P-fate is established ([Figure 6---figure supplement 2A--E](#fig6s2){ref-type="fig"}), suggesting that Dpp also functions as a positive regulator of early airway development, in addition to its repressive effect on the earliest *trh* expression. In *dpp* hypomorphs ([Figure 6D--F](#fig6){ref-type="fig"}, [Figure 6---figure supplement 2F--J](#fig6s2){ref-type="fig"}), *trh* expression is expanded to the dorsal midline and P/D specification is confined near the dorsal midline, depending on the allele severities or the residual Dpp/BMP activity in the hypomorphic conditions. In the dorsally expanded primordia of *dpp^hr92^* homozygotes, expression of the D-factors *vvl* and *btl* is detected as stripes straddling the dorsal midline ([Figure 6D--E](#fig6){ref-type="fig"}), and P-fate marker expression typically encircles the entire airway primordium except for its anterior border ([Figure 6F, I](#fig6){ref-type="fig"}, [Figure 6---figure supplement 2J](#fig6s2){ref-type="fig"}). The loss of the P-fate markers at the anterior border in *dpp^hr92^* homozygotes could be due to the activity of the D-fate inducer Hh, which is expressed just anterior to the airway primordia ([Figure 1B](#fig1){ref-type="fig"}) ([@bib37]). Consistent with the Hh-dependent anterior bias of the D-fate selection, the expression of the dorsal-distal marker *h-lacZ*, is lost in *hh* mutant ([Figure 6---figure supplement 3A--B](#fig6s3){ref-type="fig"}). Similarly, expression of *h-lacZ* is lost in *rho* and *pnt* mutants but not in *btl* mutants ([Figure 6---figure supplement 3A, C, D](#fig6s3){ref-type="fig"}). On the other hand, overactivation of Hh signaling in *wg/WNT* mutants expands *h* expression along the AP axis ([Figure 6---figure supplement 1N--Q](#fig6s1){ref-type="fig"}). Collectively, this analysis suggests that the graded Dpp/BMP activity controls the P/D fate selection at the dorsal border of the airway primordia. Wg/WNT signals impinge on the P/D-fate selection along the AP axis, while Hh modulates P/D differentiation from the anterior border. Consistent with the predominant roles of Dpp/BMP and Wg/WNT in airway primordia specification, in *Df(wg) dpp^hr92^*double mutants, the whole dorsal area of the trunk/abdominal parts of the embryo takes the airway cell fate ([Figure 6G, I](#fig6){ref-type="fig"}). In this situation, the dorsal part of the airway primordia takes the D-fate and only the ventral periphery takes the P fate ([Figure 6H, I](#fig6){ref-type="fig"}), supporting our model that Dpp/BMP and Wg/WNT are key regulators of the P/D fate selection.

Several other cues including inducers of the airway fate ([@bib12]) are expected to contribute to the P/D fate selection. At the ventral border for example, apart from the dorso-ventral gradient of Dpp/BMP, the ventro-dorsal gradient of *dEGFR* signaling ([@bib32]; [@bib38]; [@bib89]) and another cue originating from the ventro-lateral gradient of the TF Dorsal ([@bib2]; [@bib93]; [@bib124]) may orient the P/D fate selection. The exact mechanisms by which Wg/WNT, Dpp/BMP, and these other cues impinge on P/D fate selection await future research and the development of appropriate cell-specific gene inactivation methods.

Overactivation of the D-fate determinants abrogates the P-fate selection {#s2-8}
------------------------------------------------------------------------

In order to investigate how the P- and D-fates are balanced during airway cell differentiation, we analyzed the effects of overactivation of the D-fate determinants, namely RTK signaling, *hh* signaling and *vvl. argos* (*aos*) is a secreted negative feedback regulator of *dEGFR* signaling ([@bib102]) while *anterior open* (*aop*) encodes an ETS TF that antagonizes RTK signaling ([@bib90]). Upon activation of RTK signaling, *aos* is induced, while *Aop* is excluded from the nucleus and becomes degraded. In the airway primordia, *aos* expression gradually expands from the center to the periphery ([Figure 7---figure supplement 1A--E](#fig7s1){ref-type="fig"}). At early stage 12, both *aos* and Aop are preferentially detected in the proximal airways ([Figure 7---figure supplement 1E--F](#fig7s1){ref-type="fig"}). In *aop* mutants, the number of cells expressing P-fate markers is very much reduced ([Figure 7A](#fig7){ref-type="fig"}, [Figure 7---figure supplement 2A](#fig7s2){ref-type="fig"}). Moreover, compared to either of the single mutants ([Figure 7B](#fig7){ref-type="fig"}, [Figure 7---figure supplement 2A](#fig7s2){ref-type="fig"}), in *aop aos* double mutants, expression of the P-fate marker *P0144-lacZ* is virtually abolished ([Figure 7C](#fig7){ref-type="fig"}, [Figure 7---figure supplement 2A](#fig7s2){ref-type="fig"}). Similar phenotypes are observed upon tracheal overexpression of *Ras^V12^* ([Figure 7D](#fig7){ref-type="fig"}) or *s-spi* ([Figure 7E](#fig7){ref-type="fig"}) with *btl-gal4* or *trh-gal4* in an *aos* mutant background. In double mutants of *aos* and *Gap1*, a GTPase-activating protein for *Ras85D* ([@bib35]), expression of the P-fate markers *upd* and *grn* is variably reduced or abolished ([Figure 7G,H](#fig7){ref-type="fig"}). The expression of another P fate marker *P0144-lacZ* is also lost ([Figure 7F](#fig7){ref-type="fig"}, [Figure 7---figure supplement 2A--B](#fig7s2){ref-type="fig"}). Concomitantly, the distal mAb2A12/Gasp marker staining appears on the embryo outer surface ([Figure 7E--F](#fig7){ref-type="fig"}). These results suggest that *aos, Gap1,* and *aop* are parts of a negative regulatory mechanism balancing the D-fate inducing activity of RTK signaling to assure P-fate selection.10.7554/eLife.09646.022Figure 7.Overactivation of the D-fate determinants abrogates the P-fate specification.(**A--I**) Effects of RTK signaling overactivation. Proximal areas are marked by arrowheads in Tr7. In *aop* mutants (**A**), expression of the P-fate marker *P0144-lacZ* is variably decreased or lost. Compared to either single mutant (**A,B**), in *aop aos* double mutants (**C**), *P0144-lacZ* expression is virtually abolished. Note that the epidermal signals in **C** (brackets) are from other lineages. *aos* mutation, combined with *Ras^V12^* overexpression by *btl-gal4* (**D**), *s-spi* overexpression by *trh-gal4* (**E**) or *Gap1* mutation (**F**) abolish *P0144-lacZ* expression. Note that in **E** and **F**, after enhancement of mab2A12/Gasp signals, the epidermal surface staining is evident (asterisks). In *aos Gap1* double mutants, expression of the other P-fate markers (*upd* in **G** and *grn* in **H**) is variably reduced or lost, while *grn* overexpression (**I**) partially restores *P0144-lacZ* expression to the proximal areas of *aos Gap1* double mutants (arrows). (**J--P**) Effects of overactivation of *hh* or *vvl*. Overactivation of *hh* signaling by *ptc* mutation (**J,M**) or *hh* overexpression (**K,L**), either in the wild-type background (**J,K**) or *wg* mutant background (**M,L**) reduces the *P0144-lacZ-*positive cells. *salm-gal4* mediated overexpression *ci^rep^* increases the area of *P0144-lacZ-*positive P-fate cells in the dorsal stripe (**N**). The dorsal and the ventral stripes are marked with D and V in (**M,N**). *vvl* overexpression reduces or abolishes the expression region of the P-fate markers *upd* (**O**) or *P0144-lacZ* (**P**). Scale bar: 50 μm. RTK, receptor tyrosine kinase.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.022](10.7554/eLife.09646.022)10.7554/eLife.09646.023Figure 7---source data 1.Source data for [Figure 7---figure supplement 2A](#fig7s2){ref-type="fig"}.The number of metameres with any number of *P0144-lacZ*-positive cells of the indicated genotypes at stages 15/16.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.023](10.7554/eLife.09646.023)10.7554/eLife.09646.024Figure 7---source data 2.Source data for [Figure 7---figure supplement 2J](#fig7s2){ref-type="fig"}.The number of metameres with any number of *P0144-lacZ*-positive cells of the indicated genotypes at stages 15/16.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.024](10.7554/eLife.09646.024)10.7554/eLife.09646.025Figure 7---figure supplement 1.Expression of *aos* and Aop.Expression of *aos* (**A--E**) or Aop (**F**) during stages 10-11. *aos* expression in the primordia (arrowheads) expands from the central part of the primordia (**A**) to the peripheral areas (**B**) to cover all the tracheal cells (**C**). By late stage 11, *aos* expression in the distal area decreases (**D** arrows in Tr3), while expressions of both *aos* and Aop are detected in the proximal area (**E,F**, arrowheads).**DOI:** [http://dx.doi.org/10.7554/eLife.09646.025](10.7554/eLife.09646.025)10.7554/eLife.09646.026Figure 7---figure supplement 2.Requirement of the overactivated RTK signaling in the abrogation of the P-fate selection.Expression of the D-fate marker mab2A12 and the P-fate marker *P0144-lacZ* is shown. Scatter plots of the number of metameres with any number of *P0144-lacZ*-positive cells of the genotypes at stages 15/16 relating to *aos Gap1* mutants or overexpression of *Ras^V12^, s-spi* or *vvl* are summarized in (**A,J**). All p-values were calculated by Student's t-test. \*p \< 5 × 10^−2^, \*\*\*p \< 1 × 10^−3^, \*\*\*\*p \< 1 × 10^-4^, NS: Not significant. Source file is supplied in [Figure 7---source data 1](#SD5-data){ref-type="supplementary-material"},[2](#SD6-data){ref-type="supplementary-material"}. In *Gap1* mutants (**B**), P/D fate selection is comparable to *aos* mutants. Loss of *P0144-lacZ* expression in *aos Gap1* double mutants is variably suppressed by mutations of *vvl* (**C**), *hh* (**D**), *rho* (**E**), *pnt* (**F**), or *Ras85D* (**G**) but not by mutations of *sim* (**H**) or *btl* (**I**). Loss of *P0144-lacZ* expression upon overexpression of *s-spi/TGF-alpha* (**K**) is variably suppressed by mutations of *vvl* (**L**), *pnt* (**O**) or *Ras85D* (**P**), but not by *hh* mutation (**M**) nor *rho btl* double mutations (**N**). Overexpression of Bnl/dFGF does not abolish *P0144-lacZ* expression (**Q**) while simultaneous overexpression of an active form of *btl/dFGFR* with its mediator, *downstream of FGFR (dof*) variably diminished *P0144-lacZ* expression (**R**). Note that overactivation of RTK signaling in *hh* mutant background (**D,M**) results in expansion of the field expressing airway markers. Scale bar: 50 μm. RTK, receptor tyrosine kinase.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.026](10.7554/eLife.09646.026)10.7554/eLife.09646.027Figure 7---figure supplement 3.Effects of *vvl* or *s-spi* overexpression in *wg/WNT* mutant embryos.Compared to single *wg/WNT* mutants (**A**, arrowheads), the *P0144-lacZ*-positive P-fate is not established upon *arm-gal4-*mediated overexpression of *vvl* (**B**, asterisks) or *s-spi* (**C**, asterisks).**DOI:** [http://dx.doi.org/10.7554/eLife.09646.027](10.7554/eLife.09646.027)

The loss of *P0144-lacZ* expression in *aos Gap1* double mutants is partially suppressed by overexpression of the P fate determinant Grn ([Figure 7I](#fig7){ref-type="fig"}, [Figure 7---figure supplement 2A](#fig7s2){ref-type="fig"}). Reversion of the *aos Gap1* mutant phenotypes is also detected by introducing *vvl, hh, rho, Ras85D* ([@bib106]) or *pnt* mutations but not by *btl* or by *single-minded (sim)* mutations ([Figure 7---figure supplement 2A--I](#fig7s2){ref-type="fig"}). *sim* governs the ventral midline cell fate, which is one source of dEGFR signaling before stage 10 ([@bib38]; [@bib74]). Thus, these results illustrate the essential roles of *vvl, hh,* and RTK signaling components as D-fate determinants and suggest that neither the CNS midline nor *btl/dFGFR* are involved in the RTK overactivation observed in the *aos Gap1* double mutants. Similarly, *arm-gal4* mediated, ubiquitous overexpression of secreted active *spitz (s-spi*) results in loss of the P-fate marker *P0144-lacZ* ([Figure 7---figure supplement 2J--K](#fig7s2){ref-type="fig"}). This defect is also suppressed by mutations of *vvl, pnt,* or *Ras85D* but not by *btl, rho,* or *hh* mutations ([Figure 7---figure supplement 2J--P](#fig7s2){ref-type="fig"}). This suggests that *vvl* has an additional essential role in dEGFR signaling other than facilitating active dEGFR ligand production. In contrast to *s-spi, bnl* overexpression does not abolish *P0144-lacZ* expression ([Figure 7---figure supplement 1Q](#fig7s1){ref-type="fig"}). However, simultaneous overexpression of an activated form of *btl/dFGFR* and its downstream mediator *downstream of FGFR (dof*) ([@bib49]; [@bib76]; [@bib116]) reduced *P0144-lacZ* expression ([Figure 7---figure supplement 1R](#fig7s1){ref-type="fig"}) suggesting that *dEGFR* and *btl/dFGFR* share the downstream signaling pathway for P/D fate selection.

Overactivation of *hh* signaling, either by mutation of the inhibitory receptor *ptc* ([@bib20]; [@bib52]) or by *arm-gal4*-mediated *hh* overexpression, reduces the number of cells expressing P-fate markers ([Figure 7J--K](#fig7){ref-type="fig"}). Although overactivation of Hh signaling is expected to increase the expression of Wg/WNT ([@bib27]), a negative regulator of *trh* expression ([@bib121]), reduction of the P-fate cell number upon *hh* overactivation still occurs in *wg/WNT* mutant backgrounds ([Figure 7M--N](#fig7){ref-type="fig"}). Moreover, driving a repressor form of Cubitus interruptus (Ci^rep^), a mediator TF of Hh signaling ([@bib43]; [@bib75]) at the dorsal ectoderm with *salm-gal4* in *ptc wg* mutants locally increases the P-fate cell number in the dorsal side ([Figure 7N](#fig7){ref-type="fig"}). These results imply that overactivation of *hh* signaling autonomously represses the P-fate selection independent of its effect on *wg/WNT.*

Overexpression of *vvl* with *arm-gal4,* like *s-spi* overexpression reduces or abolishes the expression of the P-fate markers, *upd* or *P0144-lacZ* ([Figure 7O--P](#fig7){ref-type="fig"}), and this occurs independently of the presence of wg/WNT ([Figure 7---figure supplement 3A--C](#fig7s3){ref-type="fig"}). Collectively, the analysis indicates that expansion of the D-fate-inducing activities of RTKs, Hh or Vvl is deleterious to the P-fate selection and that the negative regulators of RTK signaling (*aos, aop* or *Gap1*) and *hh* signaling (*ptc*) ensure the selection or maintenance of the P-fate.

Differential competence of the primary branches and the TC {#s2-9}
----------------------------------------------------------

The hitherto analysis indicates that *aos* sensitizes the circuit of P/D-fate selection. We noticed that crossing of a weaker driving strain of *UAS-Ras^V12^* with *arm-gal4* causes loss of *P0144-lacZ* expression only in the *aos* mutant background while the stronger *UAS-Ras^V12^*strain is sufficient to eliminate *P0144-lacZ* expression on its own ([Figure 8---figure supplement 1A--D](#fig8s1){ref-type="fig"}). Using the weaker *UAS-Ras^V12^* strain, we demonstrate that within the D-fate group, the cells of the TC and the remaining primary branches have differential competence ([Figure 8---figure supplement 1E](#fig8s1){ref-type="fig"}). In wild-type embryos, Kni and Knrl are induced in a subset of the distal primary branches (DB, LT and GB) in response to Dpp/BMP ([@bib21]; [@bib115]). *arm-gal4-*mediated overexpression of Dpp/BMP or the active form of its co-receptor tkv^QD^ ([@bib78]) is sufficient to induce ectopic Kni in additional branches ([Figure 8A,B](#fig8){ref-type="fig"}) ([@bib115]). However, Kni levels in the TC cells is weaker compared to the more distal cells, suggesting that TC cells are less competent in inducing the D-fate marker Kni in response to Dpp/BMP signaling. When both *UAS-dpp* and the weaker line of *UAS-Ras^V12^* are simultaneously driven by *arm-gal4*, kni expression becomes homogenously induced in both the TC cells and the more distal cells ([Figure 8C](#fig8){ref-type="fig"}). This suggests that graded activity of the D-fate inducers, like RTKs may act to generate three different cell states along the PD axis of the airways. The most distal part (the primary branches) is established in response to the highest activity, the intermediate domain (TC) requires weaker activity, whereas the level of the D-factors needs to be low in the most proximal part ([Figure 8---figure supplement 1E](#fig8s1){ref-type="fig"}). Slight expansion of the P-fate only in the TC region upon Grn overexpression ([Figure 4A--C](#fig4){ref-type="fig"}) may also reflect this differential competence of TC and the remaining primary branches.10.7554/eLife.09646.028Figure 8.TC cells may define an intermediate fate between the more distal primary branches and the SB.Expression of Kni is shown together with the D-fate marker *btl-CD8GFP* and the P-fate marker *P0144-lacZ* upon overexpression of *dpp/BMP* and/or *Ras^V12^*. Arrowheads and arrows mark the P-cells and TC in Tr7, respectively. Compared to the control, *dpp/BMP* overexpression induces Kni expression in all the D-cells. But the Kni expression level is weaker in TC. The differential Kni expression levels in the primary branches and TC (**B**) become equalized by additional overexpression of *Ras^V12^* (**C**). Upon *Ras^V12^* overexpression alone (**D**), Kni expression becomes detected along the TC. Note that in all cases, *P0144-lacZ-*positive P-cells do not express Kni. Scale bar: 50 μm. SB, spiracular branch; TC, transverse connectives.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.028](10.7554/eLife.09646.028)10.7554/eLife.09646.029Figure 8---source data 1.Source data for [Figure 8---figure supplement 1D](#fig8s1){ref-type="fig"}.The number of metameres displaying *P0144-lacZ*-positive cells in the indicated genotypes at stages 15/16**DOI:** [http://dx.doi.org/10.7554/eLife.09646.029](10.7554/eLife.09646.029)10.7554/eLife.09646.030Figure 8---figure supplement 1.Characterization of the effects of the weaker and the stronger *UAS-Ras^V12^* lines.Driving the stronger *UAS-Ras^V12^* line/*Ras^V12^* (s) with *arm-gal4* (**A**) causes loss of *P0144-lacZ* expression (arrowheads in Tr7), while the weaker *UAS-Ras^V12^* line/*Ras^V12^* (w) (**C**) needs *aos* mutation (**B**) to cause loss of *P0144-lacZ* expression (arrowheads in Tr7). Scale bar: 50 μm. (**D**) Scatter plots of the number of metameres displaying *P0144-lacZ*-positive cells in the indicated genotypes at stages 15/16. All p-values were calculated by Student's t-test. \*\*p \< 2 × 10^−3^, \*\*\*\*p \< 1 × 10^−4^. A source file is supplied in [Figure 8---source data 1](#SD7-data){ref-type="supplementary-material"}. (**E**) illustrates the separation of the airway tree into three different developmental competences, SB (P-fate), TC and the remaining primary branches (both D-fates). SB, spiracular branch; TC, transverse connectives.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.030](10.7554/eLife.09646.030)

The early development of the airway primordia includes two essential aspects: first, the selection and maintenance of the airway field, and second, the selection of the P/D-fates, both of which originate from the AP and DV axis determinants of the embryo ([Figure 9](#fig9){ref-type="fig"}). More specifically, we identified a positive role of Dpp/BMP and the P/D fate factors in the establishment of the airway field. In the absence of Dpp/BMP or both P/D fate regulators, the airway field is lost. The latter phenotype could be explained in the following way in terms of P/D fate selection. Without the D-factors, the airway field is expected to uniformly take the P-fate that is promoted by *grn*. In this situation, *grn* becomes indispensable for maintenance of *trh* expression in the main airways. However, Wg/WNT, Hh, Dpp/BMP and other cues generate a centrally enriched expression field of the D-fate determinants *vvl, rho,* and *btl*, which then cooperate to repress the P fate, leaving the *grn-trh* regulation operative only in the P-region. Restoration of the P-fate in *grn vvl* double mutants suggests that the proximal multipotent fate is the default state for airway cells or that there is another factor that promotes the P-fate in the absence of *grn* and *vvl.*10.7554/eLife.09646.031Figure 9.Genetic circuits explaining the early development of the *Drosophila* airways.(**A**) Establishment of the airway field is regulated by Dpp/BMP and Wg/WNT. In each metameric unit of the *Drosophila* embryo (parasegment, PS) ([@bib97]), an airway primordium is specified just posterior to the *hh* expression domain (a posterior compartment of a segment, P). This is combinatorially controlled along the DV and AP axis. Dpp/BMP expressed in the dorsal region functions as both a repressor ([@bib53]; [@bib121]) and an activator of the airway field (this study) while Wg/WNT functions as a repressor along the AP axis. (**B**) Initiation of the P/D-fate selection by Dpp/BMP, Wg/WNT, and Hh. Each airway primordium is roughly subdivided into two regions, anterior-central (D-fate, dark green) and the peripheral (P-fate, light green). The patterning cues along the AP and DV embryo axis roughly set up this radial patterning. Along the DV axis, Dpp/BMP expressed in the dorsal region functions to discriminate the P/D-fates, at least at the dorsal edge. Dpp/BMP may also discriminate the P/D-fates at the ventral edge. Alternatively, ventral cues dependent on the Dorsal TF gradient may discriminate the P/D-fates at the ventral edge. Along the AP axis, Wg/WNT expressed in transverse stripes may discriminate the P/D-fates at each edge. Hh from the anterior border stimulates the D-fate. (**C**) Establishing the P/D-fates by the P/D-factors. The ordered Invagination of the primordia converts the centro-peripheral patterning to the proximo-distal organization along the airway tree. By completion of invagination, D-factors establish the D-fate at the expense of the P-fate. Within the D-fate, there are two groups of cells having different responsiveness to overexpression of Dpp/BMP or Grn, e.g., TC (green) and the primary branches (dark green). See text for details. AP, anterior-posterior; DV, dorso-ventral.**DOI:** [http://dx.doi.org/10.7554/eLife.09646.031](10.7554/eLife.09646.031)

Intriguingly, the *Drosophila* legs and the trachea are supposed to have evolved form common ancestor appendages ([@bib31]). The proximo-distal patterning mechanisms of these two organs are similar in that RTK activation distalizes the field ([@bib15]; [@bib33]) while initiation of the distal identity is conferred by the same set of signaling molecules (Dpp/BMP, Wg/WNT, and Hh) from the outside (for the airways) or the inside (for the legs) ([@bib29]). The proximal location of multipotent cells in the *Drosophila* airway tree resembles the conspicuous proximal localization of multipotent tracheal basal cells in the mouse lung ([@bib91]; [@bib92]) Given the prominent roles of FGFR signaling in branching morphogenesis in both flies ([@bib110]) and mice ([@bib77]; [@bib104]), the identification of a genetic mechanism for P- and D-fate selection in flies may aid future studies aiming to identify the mechanisms that spatially confine multipotent cell selection in the embryonic vertebrate lung.

Materials and methods {#s3}
=====================

Fly genetics {#s3-1}
------------

Flies kept over balancer chromosomes ([@bib66]) were grown in standard medium. We obtained the appropriate genotypes by standard genetic crosses. For overexpression of genes, we used the Gal4/UAS system ([@bib9]). Germline clones of *Ras85D^c40b^* mutants were made by FLP-DFS technique ([@bib23]; [@bib47]). Mutant embryos were identified by the expression of *twi-lacZ, ftz-lacZ, * hb-lacZ, *Ubx-lacZ, or GMR-dfd-GFP* constructs inserted on balancer chromosomes. We identified mutants harboring *dpp* mutations by selecting embryos with previously reported phenotypes in the embryo DV patterning. For collection of large numbers of virgins, we used a Y chromosome harboring *hs-hid* construct developed by R. Lehmann and M. Van Doren ([@bib109]). See Flybase ([@bib108]) for details of strains described below.

Mutant strains; *AbdB^M1^* (a gift from I. Lohmann) ([@bib71]), *btl^∆oh10^ *and *btl^∆oh24-1^*([@bib83]), *Df(os)1A* (a gift from D. Harrison) ([@bib41]), *Gap1^B2^* (a gift from N. Perrimon) ([@bib47]), *grn^7L12^* (a gift from J. Hombria) ([@bib11]), *hh^13C^* ([@bib45]), *Ras85D^∆c40b^* (a gift from N. Perrimon and C. A. Berg) ([@bib47]; [@bib101]), *rho^∆38^* (a gift from D. Andrew) ([@bib8]), *rho^7M^* (a gift from J. Skeath) ([@bib107]), *top^f24^* (a gift from K. Moses) ([@bib62]) *ut^H599^ *= *vvl^H599^* (a gift from A. Salzberg) ([@bib50]). *arm^4^* was obtained from National Institute of Genetics (NIG), Mishima, Japan. *aop^1^, aos^∆7^, bnl^P1^, Df(3R)Dl-BX12 as Df(bnl), dpp^hr92^, dpp^H46^, pnt^*∆*88^, Df(H99), hh^AC^, pnt^2^, ptc^9^, Df(2R)Exel7098* as *Df(ptc), sim^2^, top^f2^, trh^2^, Df(3L)Exel6109 as Df(vvl), wg^CX4^, Df(2L)Exel6017 as Df(wg)* were obtained from Bloomington stock center (BDSC), Indiana.

Enhancer trap strains; *1-eve-1* as *trh-lacZ* (a gift from N. Perrimon) ([@bib86]) and *P0144-lacZ* (a gift from W. Janning, Flyview), *pnt-lacZ* (a gift from M. Krasnow) ([@bib95]). *h-lacZ* was obtained from BDSC.

Enhancer reporter strains; *btl-CD8-GFP* (a gift from M. Sato) ([@bib98]), *kni-(dpp)-lacZ* ([@bib21]), and *salm-TSE-lacZ* ([@bib61]) (gifts from R. Schuh).

Gal4 and UAS strains; *btl-gal4* and *trh66-gal4* on sencond and third chromosomes (gifts from S. Hayashi) ([@bib59]; [@bib105]), *salm-gal4* (a gift from M. Llimargas) ([@bib69]), *UAS-bnl* (a gift from M. Krasnow) ([@bib110]), *UAS-btl/dFGFR* (R. Matsuda and K. Saigo), *UAS-ci^75^* (a gift from S. Ishii) ([@bib25]* *U*AS-ci^rep^ *(a gift from A. Moore) ([@bib56]* *U*AS-DIAP* (a gift from E. Kuranaga and M. Miura) ([@bib63]), *UAS-dof* (a gift from M. Affolter) ([@bib116]), *UAS-dpp* (a gift from K. Basler) ([@bib94]), *UAS-grn* (a gift from J. Hombria) ([@bib11]), *UAS-hh* ([@bib45]), *UAS-torso^4021^-btl* (a gift from E. Hafen) ([@bib30]), *UAS-Ras^V12^* (gifts from G. M. Rubin) ([@bib55]), *UAS-sspi* (a gift from B. Shilo) ([@bib103]), *UAS-vvl* and *UAS-vvl vvl^H599^ *(gifts from A. Salzberg) ([@bib50]). *arm-gal4, UAS-dEGFR* and *UAS-nGFP* were obtained from BDSC.

In situ hybridization and immunostaining {#s3-2}
----------------------------------------

Eggs were collected on apple/grape juice plates at 25°C. Embryos were bleached and fixed as previously described ([@bib85]) for 15--30 min with a 1:1 mixture of heptane and a fix solution (3.7% formaldehyde, 0.1 M Hepes pH6.9, 2 mM MgSO~4~). Embryos were dechorionated with methanol and incubated in 0.1% PBT supplemented with 0.5% BSA. Staging of embryos was done as previously described ([@bib17]).

For immunostaining, the following primary antibodies were used. Guinea-pig anti-Gasp (1:1000) ([@bib112]), Guinea-pig anti-Kni (1:300), (developed by J. Reinitz and distributed by Y. Hiromi, East Asian Segmentation Antibody Center, Mishima, Japan) ([@bib60]), rabbit anti-Trh (1:50). Mouse anti-Abd-B (1:10, donated by S. Celniker) ([@bib19]), mouse anti-Aop (1:10, donated by I. Rebay and G. M. Rubin) ([@bib90]), mouse Dcad (1:10, donated by T. Uemura) ([@bib82]), mouse mab2A12 (anti-Gasp) (1:5, donated by M. Krasnow, N. Patel and C. Goodman) ([@bib96]; [@bib112]) were obtained from Developmental Studies Hybridoma Bank (DSHB), Iowa. Commercially available antibodies were anti-LacZ (*E. coli.* β-Galactosidase) antibodies made in goat (1:500, Biogenesis, UK) or rabbit (1:1000, Cappel, Netherlands) and anti-GFP antibodies made in rabbit (1:500, JL-8 Clontech, Mountain View, CA) or mouse (1:1000, GFP20 Sigma, St. Louis, MO).

Donkey or goat biotin- or fluorescently labeled secondary antibodies made against the host species of primary antibodies were purchased from Jackson Laboratories, Sacramento, CA. Streptavidin coupled with AMCA, FITC, or Cy5 were used when necessary. For mab2A12 detection TSA amplification (PerkinElmer, Waltham, MA) was used. For detection of apoptosis, a TUNEL kit from Roche (Switzerland) was used.

Double fluorescent labeling with RNA probes and antibodies was carried out as described ([@bib39]). The following cDNA clones were used to make hybridization probes; *btl* ([@bib83]), *h* (a gift from D. Ish-Horowicz) ([@bib44]), *grn* (a gift from J. Hombria) ([@bib11]), *pnt* (a gift from C. Klambt) ([@bib58]), *salm* (a gift from R. Schuh) ([@bib61]), *upd* (a gift from D. Harrison) ([@bib41]), *vvl* (a gift from J. Casanova) ([@bib67]). DNA clones of *aos, rho* and *trh* were obtained from Drosophila Genomics Resource Center (DGRC), Indiana, USA.

Confocal images were taken by Bio-Rad (Hercules, CA) MRC1024, Olympus (Japan) Fluoview 1000 or Zeiss (Germany) LSM780. Images of controls and mutants taken by the same confocal microscopes were used for comparison. Images were processed by ImageJ and figures were prepared with Adobe Photoshop and Illustrator.
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Summary:

This paper provides a careful, relatively comprehensive genetic analysis of signaling molecules and transcription factors that orchestrate cell specification during tracheal development in *Drosophila* embryos. The study focuses on two existing cell populations, which differ in their location and developmental potential: 1. P-fate precursors, a multipotent population located proximal to the body wall and 2. D-fate precursors, a more differentiated cell pool residing distal to the body wall. First, the authors define a set of markers to visualise P and D fate precursors: btl and mab2A12 to mark D-fate and P0144-enhancer trap and upd to stain for P-fate.

They continue to identify the underlying molecular networks controlling P and D fate selection: The transcription factor Grain (grn) promotes P-fate selection, whereas vvl stimulates D-fate decision. In addition, vvl together with Hh and RTK signalling (EGF and FGF) support D-fate at the expense of P-fate. More globally, they show that gradients of BMP, Hh and Wnt regulate the two cell populations to control distal-proximal organisation of distinct tracheal cell precursors.

The paper provides a lot of good quality data that supports most of its conclusions. This data is nearly all expression patterns in mutants, or in embryos with ubiquitous over- expression of one of the effector genes. Nevertheless, the interplay between different signalling cascades to coordinate of P-fate and D-fate selection is interesting, and will serve as a basis for further analysis of this developmental system. Important concerns do need to be addressed for acceptance and these are given below.

Essential revisions:

Overall this is a compelling piece of work, but there are many places where the manuscript would benefit from improved clarity. The paper suffers from trying to deliver too much data, and some of the material in the figures is redundant. It could be improved by streamlining the text, making the figures more compact and moving redundant data sets to supplemental locations (in general we would like to minimise the use of supplemental figures and have data in the main text, but do feel here that both clarity of figures and making all data available can be better reconciled in this paper by the use of supplemental figures.). So, fewer figure panels and clearer figures will bring much required clarity.

From the outset, the definition of D- and P-fate precursors is not clear enough, and this makes it difficult to follow the aims, experimental flow and the conclusions. Including a better schematic at the very beginning illustrating i) the organization and the development of the airway system on a cellular basis, and ii) the location and definition of P-and D-fate cells and their corresponding markers would be very beneficial. The schematic in [Figure 1H](#fig1){ref-type="fig"} is not very self-explanatory and the legend is cryptic. Similarly, the schematic figures illustrating the authors\' conclusions ([Figure 9](#fig9){ref-type="fig"}) are complex and one reviewer found it difficult to follow and another would have like to see helpful aspects referred to earlier in the paper.

Some stainings especially the P-fate marker P0144-LacZ (e.g. [Figure 1B](#fig1){ref-type="fig"}, [Figure 2](#fig2){ref-type="fig"} lower panel) do not always seem to be specific and the background is very high, so that it is difficult to see what the authors claim. Virtually all the panels show whole embryos, and the magnification his not high enough to resolve individual cells. Higher magnification pictures of single segments would help to support the most important conclusions. In addition, since many of the effects shown are partial, quantifications would help to clearly define the impact of the different pathways on D-fate precursors.

Finally, virtually all of the genetic analysis is done with mutants that affect many non-airway cells as well as the airway cells, and so many of the effects shown may be indirect, non-cell autonomous effects. For instance the top and btl mutants enhance cell death in a broad swathe of ectodermal cells, and the hh mutants simply lack parts of segments that include airway precursor cells, probably because these cells were simply not generated much earlier in development. These issues might be addressed spatially and temporally targeting the suppression of gene activity to better resolve when and how the noted defects arise in the mutants. The targeted suppression of gene function by RNAi would be of value, particularly of genotypes where the effects of the mutants are likely to be very pleiotropic and there is a possibility that the effects on the trachea are secondary. This is particularly relevant to [Figure 6](#fig6){ref-type="fig"}.

Thus, while the study should prove to be useful, we think it requires some refinement before it is ready for publication.

Specific major comments:

1\) [Figure 1](#fig1){ref-type="fig"} shows the evolution of marker gene expression in the developing trachea. It would benefit from a clearer diagram indicating the markers that will be used for P and D fate in the subsequent figures.

2\) The text is somewhat unclear on the relationship between vvl and RTK signalling and at times emphasises the co-operative effects, and at times the data that the RTK ligands are partly downstream of vvl (and Hh). Tightening the summary sentences would help.

3\) [Figure 4](#fig4){ref-type="fig"}. By contrast, the authors show that P fate requires the transcription factor Grn. And that in the absence of the D fate, the Grn domain is expanded and cells acquire the default P fate. Is the D fate at all expanded in the grn mutants? It looks like it is ([Figure 4F](#fig4){ref-type="fig"} versus E), but this is not explicit in the text.

4\) [Figure 5](#fig5){ref-type="fig"}. The epistasis experiments suggest that any residual vvl expression in the grn mutants (e.g. in the grn, Hh double mutants compared to the grn, vvl mutants) is sufficient to prevent P fate development. This strongly suggests that an important role of vvl is to inhibit P fate allowing the D fate to be specified. Indeed, that P is the default fate which must be suppressed by the D-promoting molecules is basically the authors\' conclusion. However, the explanation for the effects (that there is substantial vvl expression in the hh mutants) is buried in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}. Can the explanation in the text of [Figure 5](#fig5){ref-type="fig"} be improved to make the manuscript easier to read? Given the epistasis experiments in [Figure 5](#fig5){ref-type="fig"}, and that P cells can be specified in the absence of grn (e.g. in the grn, vvl double mutants), I don\'t think it is appropriate to refer to Grn as a master-regulator of P fate in the previous section ([Figure 4](#fig4){ref-type="fig"} description).

5\) [Figure 6](#fig6){ref-type="fig"}. Analysis of Wg and Dpp mutants shows that P/D fate is strongly changed in these genotypes. This figure needs additional experiments to clarify the effects of Wg and Dpp. Is A-P and D-V patterning just compromised overall in these mutants, hence very strong effects on P and D fate in the trachea? Or, is there a direct Wg/Dpp signalling input into P and D fate? If RTK or Hh ligand expression (pathways the authors have shown to be required for P/D tracheal patterning) was examined at an earlier stage, would these be altered thus explaining the dramatic changes in the Wg/dpp mutants? An age-matched control shown within [Figure 6](#fig6){ref-type="fig"} (even if repetitive with other figures, and yes, we see that we are contradicting ourselves as we previously asked that redundancy be avoided, but it this instance it will be useful) would assist the reader. (See comments on [Figure 9](#fig9){ref-type="fig"} below). One way to address our concerns here would be to use temporal and tissue specific drivers with RNAi, particularly where concerns on pleiotropic effects can be argued to be of significant concern. Another way, not necessarily excluding this approach would be by live-imaging of phenotypes. In our editorial consultations we concluded that the latter is not a necessary requirement but leave it to the authors to best address this important concern in the manner(s) best suited.

6\) [Figure 7](#fig7){ref-type="fig"} supports the hypothesis from [Figure 5](#fig5){ref-type="fig"} that D-fate determinants suppress the default P fate. Would [Figure 7](#fig7){ref-type="fig"} be better following on from [Figure 5](#fig5){ref-type="fig"}?

[Figure 7I](#fig7){ref-type="fig"}. It appears as if there is some residual P fate in this picture? Maybe these are cells of another lineage and it would benefit from some arrows, or maybe the text needs modifying?

7\) [Figure 8](#fig8){ref-type="fig"} shows that the various branches of the D part of the trachea respond differently to Dpp signalling, suggesting that the D factors may also affect later tracheal patterning.

8\) [Figure 9](#fig9){ref-type="fig"}. This is a useful diagram but currently a bit complex. Could it be simplified? Perhaps the reader could be taken through the figure more gently by elaborating the legend? (This figure abrogates some earlier comments about [Figure 6](#fig6){ref-type="fig"}, though the text still needs to be clarified in that part). Are panels of the figure adapted from Sanson et al. 2001 just depicting their conclusions? In either case the panels should be appropriately referenced.

9\) Are these phenotypes truly representative of 100% penetrance in every genotype used? Or is there some variation which should be made explicit in the manuscript?

10\) The Introduction starts with a discussion of vertebrate pluripotency which is surprising given that the P cells are multipotent. In addition, we know of no verified reports that pluripotent (rather than multipotent) cells are retained in the normal adult as the second sentence suggests.

10.7554/eLife.09646.033

Author response

Essential revisions:

*Overall this is a compelling piece of work, but there are many places where the manuscript would benefit from improved clarity. \[...\] In addition, since many of the effects shown are partial, quantifications would help to clearly define the impact of the different pathways on D-fate precursors.*

Thank you very much for your involvement in improving the initialversion of our manuscript. We understand that many of the problems with figures/text would have arisen from insufficient data organization, explanations, lower magnification and lack of quantitative data. We have corrected these by reorganizing the figures and supplements, by adding some more schematics, some enlarged pictures and quantifications according to the detailed guidance.

*Finally, virtually all of the genetic analysis is done with mutants that affect many non-airway cells as well as the airway cells, and so many of the effects shown may be indirect, non-cell autonomous effects. For instance the top and btl mutants enhance cell death in a broad swathe of ectodermal cells, and the hh mutants simply lack parts of segments that include airway precursor cells, probably because these cells were simply not generated much earlier in development. These issues might be addressed spatially and temporally targeting the suppression of gene activity to better resolve when and how the noted defects arise in the mutants. The targeted suppression of gene function by RNAi would be of value, particularly of genotypes where the effects of the mutants are likely to be very pleiotropic and there is a possibility that the effects on the trachea are secondary. This is particularly relevant to [Figure 6](#fig6){ref-type="fig"}.*

Whether signaling molecules have a direct or an indirect effect on different P/D cell fates in the airway tree is an important issue. Ideally, this could be done with Gal4 drivers expressed very early in airway primordial specification and before/during the P/D fate specification. The widely used btl-gal4 is not efficient for this purpose, which probably reflects that btl-gal4 mediated overexpression of proteins occurs after the invagination of the primordial cells. We tried trh(66)-gal4, GMR15F01(trh), GMR19A07 (vvl), VT041289 (ems) and VT49279 (stg). Except for GMR19A07 (vvl), which is expressed in a different pattern from the reported one, all drove UAS-nGFP mediated GFP expression earlier but much weaker than btl-gal4. Expression of dominant negative form of the effector TF of the hh signaling pathway, cubitus interruptus, ci(rep) with any of these drivers did not give significant effects on the P/D fate selection. We did the same experiments in a sensitized background (vvl/vvl hh mutants) by recombining each of the gal4 lines in hh/vvl mutants. But so far we have not obtained positive results. We also utilized ptc wg double mutant condition where only small number of the P fate cells are specified in the dorsal and ventral stripes of the abdominal segments. Strong overexpression of ci(rep) in the dorsal ectoderm with salm-gal4 locally increased the P-fate cell number in the dorsal stripe implying that hh signaling acts cell autonomously in P/D fate selection ([Figure 7N](#fig7){ref-type="fig"}). We expect that more rigorous experiments would be possible when a stronger early gal4 driver becomes available.

With our current data, we agree with the reviewers that hh signaling could have non-autonomous effects on the airway development. arm-gal4 mediated overexpression of s-spi in hh mutants results in a continuous band of mab2A12 positive airway cells over many segments ([Figure 7---figure supplement 2M](#fig7s2){ref-type="fig"}), which is also seen in wg mutants. dEGFR signaling enhances Wg degradation (Cell, 2001 (105,613-624)). We speculate that overactivation of RTK signaling degraded the potentially remaining small amount of Wg in hh mutants, which results in expansion of the airway primordia.

Hh is known to be a positive regulator of trh expression (Development 128:1599-1606). We agree with the reviewer that there would be some contribution of this hh function to the loss or reduction of the D-fate in hh mutants. However, we think that a more direct role of hh in the D-fate specification needs to be assumed to account for the expansion of the P-fate in hh vvl double mutants and in some metameres of single hh mutants.

In summary, we included the new data in [Figure 7M--N](#fig7){ref-type="fig"} and interpreted that they imply an autonomous role hh signaling in the trachea and also noted that the detailed mechanism of hh and wg signaling would have to await the development of better genetic tools and further experimentation (end of subsection "Wg/WNT and Dpp/BMP signaling converge on the P/D-fate selection").

*Thus, while the study should prove to be useful, we think it requires some refinement before it is ready for publication.*

*Specific major comments: 1) [Figure 1](#fig1){ref-type="fig"} shows the evolution of marker gene expression in the developing trachea. It would benefit from a clearer diagram indicating the markers that will be used for P and D fate in the subsequent figures.*

We have added a guidance sketch illustrating airway development, the expression of the signaling molecules and the positions of cells acquiring the P/D fates.

*2) The text is somewhat unclear on the relationship between vvl and RTK signalling and at times emphasises the co-operative effects, and at times the data that the RTK ligands are partly downstream of vvl (and Hh). Tightening the summary sentences would help.*

We have tried to be clearer in the text on the relationships of vvl and RTKs (Results and Discussion).

*3) [Figure 4](#fig4){ref-type="fig"}. By contrast, the authors show that P fate requires the transcription factor Grn. And that in the absence of the D fate, the Grn domain is expanded and cells acquire the default P fate. Is the D fate at all expanded in the grn mutants? It looks like it is ([Figure 4F](#fig4){ref-type="fig"} versus E), but this is not explicit in the text.*

Two scenarios could explain loss of the P fate in grn mutants. The P fate is transformed to the D fate or the P cells are simply lost. Halving the airway cell number in CycA mutant reduced but did not abolish the P0144-lacZ positive cells ([Figure 4---figure supplement 1K](#fig4s1){ref-type="fig"}). In contrast, we detected that the Trh positive cell number in the TC/SB region is reduced by around 10 cells in grn mutants ([Figure 4G, H](#fig4){ref-type="fig"}). These results suggest that the P fate cells are selectively lost in grn mutants. However, this cannot be explained simply by loss of Trh expression in the P-region because arm-gal4 mediated overexpression of Trh does not restore P0144-lacZ expression in grn mutants ([Figure 4---figure supplement 1F, H](#fig4s1){ref-type="fig"}). Together with the data that grn overexpression expands the P-fate to the D-region ([Figure 4B--C](#fig4){ref-type="fig"}), we suggest that grn functions in 2 ways, first to establish Trh expression in the P-region and second to induce the P-fate (subsection "Grn promotes the P-fate selection").

*4) [Figure 5](#fig5){ref-type="fig"}. The epistasis experiments suggest that any residual vvl expression in the grn mutants (e.g. in the grn, Hh double mutants compared to the grn, vvl mutants) is sufficient to prevent P fate development. This strongly suggests that an important role of vvl is to inhibit P fate allowing the D fate to be specified. Indeed, that P is the default fate which must be suppressed by the D-promoting molecules is basically the authors\' conclusion. However, the explanation for the effects (that there is substantial vvl expression in the hh mutants) is buried in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}. Can the explanation in the text of [Figure 5](#fig5){ref-type="fig"} be improved to make the manuscript easier to read? Given the epistasis experiments in [Figure 5](#fig5){ref-type="fig"}, and that P cells can be specified in the absence of grn (e.g. in the grn, vvl double mutants), I don\'t think it is appropriate to refer to Grn as a master-regulator of P fate in the previous section ([Figure 4](#fig4){ref-type="fig"} description).*

Without D factors, the airway fields uniformly take the P-fate. In this situation, grn becomes indispensable for all trh expression in the main airway, probably through its effect on the maintenance of trh expression ([Figure 9C](#fig9){ref-type="fig"}). When the D-fate is induced in the anterior-central region of the airway primordia as in wild type, this grn-to-trh regulation is left active only in the P-region. In grn mutants, both the P-fate and the P-region are lost. So we would still prefer to call grn a master regulator of the P-fate.

In grn vvl double mutants, the normal P-region is expected to be lost as in grn single mutants and some of the D-region that is transformed to take the P-fate also would lose trh expression. Accordingly, the trh expressing area is very small in grn vvl double mutants ([Figure 5F](#fig5){ref-type="fig"}). The P-fate in grn vvl double mutants would have arisen from the normal D-region. We assume that there is another P-fate promoter in the D-region or that the default fate of the D-region is the P-fate. In grn hh double mutants, metameres corresponding to those that lose vvl expression in hh single mutants become grn hh vvl triple mutant, which would lead to loss of trh expression as seen in Tr3 of [Figure 5G](#fig5){ref-type="fig"}.

*5) [Figure 6](#fig6){ref-type="fig"}. Analysis of Wg and Dpp mutants shows that P/D fate is strongly changed in these genotypes. This figure needs additional experiments to clarify the effects of Wg and Dpp. Is A-P and D-V patterning just compromised overall in these mutants, hence very strong effects on P and D fate in the trachea? Or, is there a direct Wg/Dpp signalling input into P and D fate? If RTK or Hh ligand expression (pathways the authors have shown to be required for P/D tracheal patterning) was examined at an earlier stage, would these be altered thus explaining the dramatic changes in the Wg/dpp mutants? An age-matched control shown within [Figure 6](#fig6){ref-type="fig"} (even if repetitive with other figures, and yes, we see that we are contradicting ourselves as we previously asked that redundancy be avoided, but it this instance it will be useful) would assist the reader. (See comments on [Figure 9](#fig9){ref-type="fig"} below). One way to address our concerns here would be to use temporal and tissue specific drivers with RNAi, particularly where concerns on pleiotropic effects can be argued to be of significant concern. Another way, not necessarily excluding this approach would be by live-imaging of phenotypes. In our editorial consultations we concluded that the latter is not a necessary requirement but leave it to the authors to best address this important concern in the manner(s) best suited.*

We have added schematic panels to depict and explain the phenotypes of each mutant ([Figure 6I](#fig6){ref-type="fig"}). Our aims were initial description of mutant phenotypes regarding the P/D fate discrimination and presentation of possible mechanistic explanation of the phenotypes. We agree that whether the effects of wg/dpp/hh are direct or indirect is an important issue. We added some experiments, our interpretation and stated in the text that this issue is an open question for future experiments until a strong early gal4 driver becomes available.

6\) [Figure 7](#fig7){ref-type="fig"} supports the hypothesis from [Figure 5](#fig5){ref-type="fig"} that D-fate determinants suppress the default P fate. Would [Figure 7](#fig7){ref-type="fig"} be better following on from [Figure 5](#fig5){ref-type="fig"}?

*[Figure 7I](#fig7){ref-type="fig"}. It appears as if there is some residual P fate in this picture? Maybe these are cells of another lineage and it would benefit from some arrows, or maybe the text needs modifying?*

We had thought of both figure orders in the initial submission and we had chosen the current figure order. The main reasons for this choice were that wg mutant phenotypes need to be described before hh overexpression experiments due to the hh-wg mutual regulation and that wg mutant phenotypes are better explained together with dpp mutant phenotypes. So instead of changing the figure order, we have tried to make the flow smoother by adding some phrases connecting the text part corresponding to [Figure 5](#fig5){ref-type="fig"} to those corresponding to [Figure 7](#fig7){ref-type="fig"}.

Also, we clarified in the figure legend that the aop aos mutant panel ([Figure 7C](#fig7){ref-type="fig"} in the revised version and [Figure 7I](#fig7){ref-type="fig"} in the old version) shows signals from other lineages.

*7) [Figure 8](#fig8){ref-type="fig"} shows that the various branches of the D part of the trachea respond differently to Dpp signalling, suggesting that the D factors may also affect later tracheal patterning.*

Yes, we agree.

*8) [Figure 9](#fig9){ref-type="fig"}. This is a useful diagram but currently a bit complex. Could it be simplified? Perhaps the reader could be taken through the figure more gently by elaborating the legend? (This figure abrogates some earlier comments about [Figure 6](#fig6){ref-type="fig"}, though the text still needs to be clarified in that part). Are panels of the figure adapted from Sanson et al. 2001 just depicting their conclusions? In either case the panels should be appropriately referenced.*

We have added a general guidance description and a drawing of embryo segmentation and airway primordia specification in the introduction and [Figure 1](#fig1){ref-type="fig"}. We added some schematic panels in [Figure 6](#fig6){ref-type="fig"} to explain the dpp/wg phenotypes. We also tried to make [Figure 9](#fig9){ref-type="fig"} and its legend better. We had referenced Sanson et al. in the initial version of our manuscript as a relatively recent guide for segmentation and parasegment boundaries in the *Drosophila* embryos. Rather than adopting any specific model figures of others, our schematic figures had been produced by us based on our understanding of brilliant work of others on *Drosophila* ectoderm patterning.

*9) Are these phenotypes truly representative of 100% penetrance in every genotype used? Or is there some variation which should be made explicit in the manuscript?*

We have added quantification data to figures and texts.

*10) The Introduction starts with a discussion of vertebrate pluripotency which is surprising given that the P cells are multipotent. In addition, we know of no verified reports that pluripotent (rather than multipotent) cells are retained in the normal adult as the second sentence suggests.*

We have corrected this mistake.
